Tags:DeliveryDevelopmentDrugHealthTechMedtechProductSkinSpecialtyTechnology
Agile Therapeutics is a forward-thinking women's healthcare company dedicated to fulfilling the unmet health needs of today’s women. Twirla® (levonorgestrel and ethinyl estradiol) transdermal system and our product candidates are designed to provide women with contraceptive options that offer freedom from taking a daily pill, without committing to a longer-acting method. Twirla® and our pipeline products are based on our proprietary transdermal patch technology, called Skinfusion®, which is designed to allow drug delivery through the skin.
Location: United States, New Jersey
Member count: 11-50
Total raised: $175M
Founded date: 1997

Investors 5

Funding Rounds 5

DateSeriesAmountInvestorsDeal News
01.03.2021-$45MPerceptive...marketscre...
24.02.2015-$25M-aislingcap...
20.01.2015-$20M-aislingcap...
19.07.2012Series C$40M-finsmes.co...
14.06.2010Series B$45M-finsmes.co...

Mentions in press and media 26

DateTitleDescriptionCategoryAuthorSource
25.05.2023Agile Ther...---globenewsw...
22.05.2023Agile Ther...---globenewsw...
11.05.2023Agile Ther.../EIN News/ -- Twirla Delivers ...--einpresswi...
06.07.2022Agile Ther...PRINCETON, N.J., July 06, 2022...--globenewsw...
01.07.2022Agile Ther...PRINCETON, N.J., July 01, 2022...--globenewsw...
11.04.2022Agile Ther...PRINCETON, N.J., April 11, 202...--globenewsw...
14.03.2022Agile Ther...PRINCETON, N.J., March 14, 202...--globenewsw...
14.03.2022Agile Ther...PRINCETON, N.J., March 14, 202...--globenewsw...
02.11.2021Agile Ther...Prescription Demand Growth Con...--marketscre...
02.11.2021AGILE THER...AGILE THERAPEUTICS REPORTS THI...--marketscre...
Show more